AI pioneer Innoplexus and phytopharmaceutical company DrD are partnering toRead More
Partnering to unlock the true potential of cannabis in medical care
Archives: News
AI-based drug development to broaden gap between pharmaceuticals
Local pharmaceutical firms should brace for a new era where drugmakers take advantage of artificial intelligence (AI) to develop a new medicine, experts said. The AI-using new drug development has already become the latest trend and doing so will save cost and time, they said at a news conference at the AI Pharma Korea Conference …
AI-based drug development to broaden gap between pharmaceuticals Read More »
Google for Pharma
Indian and Swabian Together with friends from India, Gunjan Bhardwaj has successfully launched Innoplexus, a sophisticated ecosystem of continuous analytics, powered by artificial intelligence and machine learning.The goal: Innoplexus wants to become the European champion for AI. The chances: excellent. At 35, Gunjan Bhardwaj was an aspiring management consultant at Ernst & Young. The atmosphere …
We want to democratize data
Dr. Gunjan Bhardwaj is the founder and CEO of Innoplexus AG. With the help of artificial intelligence, blockchain and big data analysis applications, its iPlexus software has crawled over 300 terabytes of relevant clinical and medical data and put them in a logical context, being constantly updated and delivered to the workstations of customers in …
How artificial intelligence impacts preventative care
With a dramatic rise in physician burnout and many physicians exiting the field prematurely, the health care industry is looking to artificial intelligence (AI) to provide much needed support. AI can impact physicians’ workloads through treatment plan designs and repetitive jobs assistance to data mining through millions of medical records. AI has already entered the …
How artificial intelligence impacts preventative care Read More »
More transparency would bolster big pharma’s image
It’s no surprise that the public hates Big Pharma. They rank just under the government on most Americans’ despised institution list.
Innoplexus is working on solutions in response to GDPR and other data privacy restrictions
Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to
Why AI and blockchain are the solutions to developing orphan drug
We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets. An orphan disease is a medical condition or disorder that affects less than 200,000 people in the US. The National Institutes of Health (NIH) has classified as many …
Why AI and blockchain are the solutions to developing orphan drug Read More »
Who will be the disruptor that pharma is waiting for?
Companies that thrive on sustaining products over a long period are always at risk of classic disruptive innovation—losing business to a smaller company with fewer resources that jumps in, improves a product, makes it more affordable, and broadens its appeal to more people. Disruptive innovators create new markets and reshape existing ones. Take, for instance, …
Who will be the disruptor that pharma is waiting for? Read More »
Blockchain can take pharma collaboration and innovation to new heights
The idea that a company’s success depends on how much it can leverage the skills of its employees’ bright minds is rapidly becoming an outdated concept. Companies that are equipped with technologies for collaborating with a vast pool of global talent will build a competitive advantage. Collaboration is essential for innovation and efficiency. Open source …
Blockchain can take pharma collaboration and innovation to new heights Read More »